Published in Mol Med on February 12, 2014
Plasma butyrylcholinesterase regulates ghrelin to control aggression. Proc Natl Acad Sci U S A (2015) 0.99
Predicted overlapping microRNA regulators of acetylcholine packaging and degradation in neuroinflammation-related disorders. Front Mol Neurosci (2014) 0.96
Fear and C-reactive protein cosynergize annual pulse increases in healthy adults. Proc Natl Acad Sci U S A (2014) 0.88
Molecular Mechanisms Regulating LPS-Induced Inflammation in the Brain. Front Mol Neurosci (2016) 0.84
Dysregulated cholinergic network as a novel biomarker of poor prognostic in patients with head and neck squamous cell carcinoma. BMC Cancer (2015) 0.78
Reduced serum butyrylcholinesterase activity indicates severe systemic inflammation in critically ill patients. Mediators Inflamm (2015) 0.77
Physiological roles for butyrylcholinesterase: A BChE-ghrelin axis. Chem Biol Interact (2016) 0.76
Reduced butyrylcholinesterase activity is an early indicator of trauma-induced acute systemic inflammatory response. J Inflamm Res (2016) 0.75
Weakened cholinergic blockade of inflammation associates with diabetes-related depression. Mol Med (2016) 0.75
The Protein Data Bank. Nucleic Acids Res (2000) 187.10
Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature (2000) 11.49
Heart-rate recovery immediately after exercise as a predictor of mortality. N Engl J Med (1999) 7.59
Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit. Science (2011) 5.87
Heart-rate profile during exercise as a predictor of sudden death. N Engl J Med (2005) 4.85
Acute stress facilitates long-lasting changes in cholinergic gene expression. Nature (1998) 3.46
Acetylcholinesterase--new roles for an old actor. Nat Rev Neurosci (2001) 2.87
Neutrophil/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients undergoing angiography. Atherosclerosis (2012) 2.38
Open "back door" in a molecular dynamics simulation of acetylcholinesterase. Science (1994) 2.37
MicroRNA-132 potentiates cholinergic anti-inflammatory signaling by targeting acetylcholinesterase. Immunity (2009) 2.33
Assessment of autonomic function in cardiovascular disease: physiological basis and prognostic implications. J Am Coll Cardiol (2008) 2.10
Genetic predisposition to adverse consequences of anti-cholinesterases in 'atypical' BCHE carriers. Nat Med (1995) 1.87
Alteration of the microRNA network during the progression of Alzheimer's disease. EMBO Mol Med (2013) 1.54
Impact of estimated glomerular filtration rate on vascular disease extent and adverse cardiovascular events in patients without chronic kidney disease. Can J Cardiol (2013) 1.52
Understanding immunity requires more than immunology. Nat Immunol (2010) 1.38
Prognostic value of heart rate increase at onset of exercise testing. Circulation (2007) 1.28
Hippocampal microRNA-132 mediates stress-inducible cognitive deficits through its acetylcholinesterase target. Brain Struct Funct (2012) 1.21
Structures of human acetylcholinesterase in complex with pharmacologically important ligands. J Med Chem (2012) 1.20
Stress-induced epigenetic transcriptional memory of acetylcholinesterase by HDAC4. Proc Natl Acad Sci U S A (2012) 1.16
Cholinergic status modulations in human volunteers under acute inflammation. J Mol Med (Berl) (2007) 1.15
Prognostic value of heart rate recovery in patients with heart failure. Am Heart J (2006) 1.14
Sustained augmentation of parasympathetic tone with angiotensin-converting enzyme inhibition in patients with congestive heart failure. J Am Coll Cardiol (1993) 1.09
Suppressing immunosuppression after stroke. N Engl J Med (2011) 1.05
Serum cholinesterase activities distinguish between stroke patients and controls and predict 12-month mortality. Mol Med (2010) 1.04
It takes nerve to dampen inflammation. Nat Immunol (2005) 1.02
Evidence for impaired vagus nerve activity in heart failure. Heart Fail Rev (2011) 1.01
Butyrylcholinesterase activity, cardiovascular risk factors, and mortality in middle-aged and elderly men and women in Jerusalem. Clin Chem (2006) 0.98
MicroRNA-132 modulates cholinergic signaling and inflammation in human inflammatory bowel disease. Inflamm Bowel Dis (2013) 0.97
Relation of heart rate parameters during exercise test to sudden death and all-cause mortality in asymptomatic men. Am J Cardiol (2008) 0.96
Cholinesterases as biomarkers for parasympathetic dysfunction and inflammation-related disease. J Mol Neurosci (2013) 0.93
Hydrolytic and nonenzymatic functions of acetylcholinesterase comodulate hemopoietic stress responses. J Immunol (2006) 0.93
Routinely available biomarkers improve prediction of long-term mortality in stable coronary artery disease: the Vienna and Ludwigshafen Coronary Artery Disease (VILCAD) risk score. Eur Heart J (2012) 0.93
Inherited and acquired interactions between ACHE and PON1 polymorphisms modulate plasma acetylcholinesterase and paraoxonase activities. J Neurochem (2005) 0.87
Chronotropic incompetence and mortality in middle-aged men with known or suspected coronary heart disease. Eur Heart J (2008) 0.87
Association of decreased variation of R-R interval and elevated serum C-reactive protein level in a general population in Japan. Int Heart J (2006) 0.86
Depression of efferent parasympathetic control of heart rate in rats with myocardial infarction: effect of losartan. J Cardiovasc Pharmacol (1998) 0.84
Structural study of the complex stereoselectivity of human butyrylcholinesterase for the neurotoxic V-agents. J Biol Chem (2011) 0.83
Butyrylcholinesterase interactions with amylin may protect pancreatic cells in metabolic syndrome. J Cell Mol Med (2011) 0.80
The development of anemia of inflammation during acute myocardial infarction. Int J Cardiol (2010) 0.79
Prevalence and predictors of slow flow in angiographically normal coronary arteries. Clin Hemorheol Microcirc (2012) 0.78
Quantum dot labeling of butyrylcholinesterase maintains substrate and inhibitor interactions and cell adherence features. ACS Chem Neurosci (2010) 0.77